Cite

HARVARD Citation

    Misgav, M. et al. (2021). Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real‐world data. Haemophilia. 27 (2), pp. 253-260. [Online]. 
  
Back to record